Skip to content

Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient

Bio-adrenomedullin (Bio-ADM) as a Biomarker of Refilling in Chronic Hemodialysis Patient

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05339009
Acronym
REFILBIOADM
Enrollment
150
Registered
2022-04-21
Start date
2022-04-01
Completion date
2023-05-01
Last updated
2022-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease 5D

Keywords

Chronic kidney disease, Extracorporeal purification, Bio-ADM, Vascular refilling rate

Brief summary

Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) the predictive value of bio-adrenomedullin (bio-ADM) level on vascular refilling rate.

Interventions

BIOLOGICALBioADM determination in plasma

BioADM determination in plasma

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic Kidney Disease patient on dialysis (stage 5D) for more than 1 month * Anuric patient

Exclusion criteria

* Patient protected by law * Patient under guardianship ou curatorship * Patient deprived of liberty

Design outcomes

Primary

MeasureTime frameDescription
Relationship between bio-ADM level and vascular refilling rateDay 1The refilling rate will be assessed by the ratio of relative blood volume and UF max

Secondary

MeasureTime frameDescription
Bio-ADM value according to comorbidity factorsDay 1Bio-ADM value according to comorbidity factors (diabetes, heart failure and low-grade inflammation)

Countries

France

Contacts

Primary ContactJean-Paul CRISTOL, MD PhD
jp-cristol@chu-montpellier.fr+33 467 338315
Backup ContactMarion MORENA CARRERE, PhD
m-morenacarrere@chu-montpellier.fr+33 411 759893

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026